|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Non-current assets | |||||||||
| Goodwill | |||||||||
| Intangible assets | |||||||||
| Property, plant and equipment | |||||||||
| Other non-current assets | |||||||||
| Derivative financial instruments | |||||||||
| Deferred tax assets | |||||||||
| Total non-current assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Inventories | |||||||||
| Trade and other receivables | |||||||||
| Current tax receivable | |||||||||
| Indemnification assets | |||||||||
| Derivative financial instruments | |||||||||
| Total current assets | |||||||||
| Assets | |||||||||
| Current liabilities | |||||||||
| Trade and other payables | |||||||||
| Current tax payable | |||||||||
| Provisions | |||||||||
| Loans and borrowings | |||||||||
| Derivative financial instruments | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities | |||||||||
| Loans and borrowings | |||||||||
| Employee benefits | |||||||||
| Other non-current liabilities | |||||||||
| Provisions | |||||||||
| Derivative financial instruments | |||||||||
| Deferred tax liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Net assets | |||||||||
| Equity | |||||||||
| Share capital and capital reserve | |||||||||
| Share-based compensation reserve | |||||||||
| Translation reserve | |||||||||
| Other reserves | |||||||||
| Retained earnings | |||||||||
| Equity | |||||||||
Loading...
